Ensign Peak Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$165K Sell
3,485
-2,300
-40% -$118K ﹤0.01% 1465
2026
Q1
$343K Buy
5,785
+2,600
+82% +$169K ﹤0.01% 1076
2025
Q4
$196K Sell
3,185
-6,900
-68% -$422K ﹤0.01% 1326
2025
Q3
$629K Sell
10,085
-8,550
-46% -$595K ﹤0.01% 1280
2025
Q2
$1.49M Hold
18,635
﹤0.01% 1028
2025
Q1
$1.6M Hold
18,635
﹤0.01% 1009
2024
Q4
$1.46M Hold
18,635
﹤0.01% 1105
2024
Q3
$1.34M Hold
18,635
﹤0.01% 1148
2024
Q2
$1.28M Hold
18,635
﹤0.01% 1131
2024
Q1
$1.35M Sell
18,635
-940
-5% -$62.9K ﹤0.01% 1131
2023
Q4
$1.2M Hold
19,575
﹤0.01% 1240
2023
Q3
$1.12M Hold
19,575
﹤0.01% 1109
2023
Q2
$1.16M Hold
19,575
﹤0.01% 1140
2023
Q1
$1.23M Buy
19,575
+800
+4% +$50K ﹤0.01% 1083
2022
Q4
$1.18M Hold
18,775
﹤0.01% 1040
2022
Q3
$936K Hold
18,775
﹤0.01% 1105
2022
Q2
$1.1M Hold
18,775
﹤0.01% 1069
2022
Q1
$994K Hold
18,775
﹤0.01% 1209
2021
Q4
$1.14M Sell
18,775
-29,280
-61% -$1.74M ﹤0.01% 1206
2021
Q3
$2.7M Hold
48,055
0.01% 943
2021
Q2
$2.5M Hold
48,055
0.01% 990
2021
Q1
$2.12M Hold
48,055
﹤0.01% 1087
2020
Q4
$1.68M Sell
48,055
-1,600
-3% -$56.8K ﹤0.01% 1165
2020
Q3
$1.81M Hold
49,655
﹤0.01% 1022
2020
Q2
$1.86M Hold
49,655
0.01% 1006
2020
Q1
$1.82M Sell
49,655
-45,095
-48% -$1.75M 0.01% 878
2019
Q4
$3.84M Buy
+94,750
New +$3.53M 0.01% 728

Other funds holding PBH

Ensign Peak Advisors's PBH Position: Q2 2026 in Review

Ensign Peak Advisors reduced its Prestige Consumer Healthcare (PBH) stake by 40% in Q2 2026, selling an estimated $118K and leaving 3,485 shares worth $165K. The position accounts for ﹤0.01% of the portfolio, ranked #1465.

Ensign Peak Advisors first reported a position in PBH in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.84M in Q4 2019. 318 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Ensign Peak Advisors held 3,485 shares of Prestige Consumer Healthcare worth $165K as of Q2 2026.
  • Ensign Peak Advisors sold 2,300 Prestige Consumer Healthcare shares in Q2 2026, an estimated $118K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1465 holding.
  • Ensign Peak Advisors first reported a position in Prestige Consumer Healthcare in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's Prestige Consumer Healthcare position peaked at $3.84M in Q4 2019.
  • 318 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.